Angiotensin II receptor antagonist: Difference between revisions
Jump to navigation
Jump to search
imported>Larry Sanger No edit summary |
imported>Louise Valmoria m ({{subpages}}) |
||
| Line 1: | Line 1: | ||
== | {{subpages}} | ||
==Mechanism of action== | |||
Angiotensin II receptor antagonists block [[angiotensin]] II AT<sub>1</sub> receptors. | Angiotensin II receptor antagonists block [[angiotensin]] II AT<sub>1</sub> receptors. | ||
| Line 7: | Line 8: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 19:31, 6 December 2007
Mechanism of action
Angiotensin II receptor antagonists block angiotensin II AT1 receptors.
Adverse effects
Angiotensin II receptor antagonists can cause hyperkalemia, but the rise in potassium may be less that occurs with angiotensin-converting enzyme inhibitors.[1]
References
- ↑ Bakris GL, Siomos M, Richardson D, et al (2000). "ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group". Kidney Int. 58 (5): 2084–92. DOI:10.1111/j.1523-1755.2000.00381.x. PMID 11044229. Research Blogging.